Avanos Medical (AVNS)
(Delayed Data from NYSE)
$21.18 USD
+1.79 (9.23%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $21.18 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVNS 21.18 +1.79(9.23%)
Will AVNS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
Globus Medical (GMED) Up 7.4% Since Last Earnings Report: Can It Continue?
Why Is Integra (IART) Up 26% Since Last Earnings Report?
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
Other News for AVNS
Notable Two Hundred Day Moving Average Cross - AVNS
What's Driving Establishment Labs Holdings Inc's Surprising 19% Stock Rally?
Avanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply Chain
Avanos Medical Appoints New SVP for Supply Chain Optimization
Avanos price target lowered by $7 at H.C. Wainwright, here's why